The instability of biomarkers in serum may explain the inconsistent results from the literature; for example, EGF has been reported to be elevated [53], decreased [54], or not significantly different [55] in sera from ovarian cancer patients compared to healthy controls. This evidence concerns the gene EGF and ovarian carcinoma.